Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,207.2
-11.0 (-0.34%)

 

  • STI Straits Times Index
    3,207.2
    -11.0 (-0.34%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.6
    -11.5 (-0.72%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,627.1
    -1.6 (-0.01%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,524.4
    -37.9 (-1.06%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,860.5
    -237.7 (-0.82%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,535.1
    -67.1 (-1.02%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 977.5M
  • Value: 569.5M
  • Rise: 88
  • Fall: 187
  • Unch: 476

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Raffles Edu0.080+0.013
Tritech0.029-
Geo Energy Res0.335-0.050
Beverly JCG0.001-
Rex Intl0.340-0.010
Shen Yao0.003-
Jiutian Chemical0.087-0.002
Oceanus0.040-
Hatten Land0.059-0.001
Metal Component0.060-0.002

World Indices

World Indices
Name Last Change
Nasdaq 15,235.8 +0.1
HSI 25,628.6 -0.1
HSCEI 9,074.5 -19.3
Jakarta 6,535.1 -67.1
Nikkei 225 28,860.1 -238.1
SSE Comp 3,525.1 -37.2
Shanghai A 3,694.5 -38.9
Shanghai B 268.9 -7.3
KOSPI 3,025.1 -0.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

XERIS BIOPHARMA HLDGS INC XERIS BIOPHARMA HLDGS INC
Updated on 27 Oct 2021 (End of trading day)
Last (USD): 1.830 Change: -0.040 High: 1.865 Remarks: -
Change (%): -2.14 Low: 1.800
Open 1.850 Yesterday's Close 1.87
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,116,008 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.73146 Trailing EPS (USD) e -0.67242 NAV (USD) b 0.1596
PE a - Trailing PE f - Price / NAV b 11.4662
Dividend (USD) d - Cash In Hand (USD) g 0.5104 Issued & Paid-up Shares c 124,600,000
Dividend Yield (%) d - Price / Cash In Hand g 3.585 Treasury Shares h -
Market Cap (M) 228.018 Enterprise Value (M) 199.516
Piotroski F Score 3 Exchange Code XERS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 84.62 Free Float (%) 52.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 08 Oct 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 14 Jun 2018.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference XERIS BIOPHARMA HLDGS INC NASDAQ 228.018 - - 11.4662 -
Industry Biotechnology NASDAQ 2,820.304 106.306 106.381 6.4889 0.582
Local Peer MODERNA INC NASDAQ 137,594.848 - 39.370 20.5243 -
Local Peer GILEAD SCIENCES INC NASDAQ 83,716.894 680.632 16.218 4.2489 4.074
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 67,328.809 3,886.379 13.710 10.3550 -
Local Peer ILLUMINA INC NASDAQ 64,479.565 98.292 83.958 12.4478 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 63,060.650 17.950 10.162 4.1687 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 46,940.902 17.311 23.568 5.1043 -
Local Peer BIOGEN INC NASDAQ 38,184.835 9.545 24.702 3.6611 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 34,276.575 - - 9.5036 -
Local Peer SEAGEN INC NASDAQ 31,767.496 51.766 53.188 9.3674 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 22,718.984 - - 26.6228 -
Local Peer BIO-TECHNE CORP NASDAQ 20,002.508 142.545 142.545 12.7977 0.249
Local Peer 10X GENOMICS INC NASDAQ 17,624.173 - - 22.4631 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ACCELERON PHARMA (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ALKERMES PLC (NASDAQ), 23ANDME HOLDING CO (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), LYELL IMMUNOPHARMA INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), INSMED INC (NASDAQ), CYTOKINETICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), EDITAS MEDICINE INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INSTIL BIO INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SEER INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), ALECTOR INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CORTEXYME INC (NASDAQ), KADMON HLDGS INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ALLOVIR INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), INHIBRX INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), CARIBOU BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), UNIQURE N.V. (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OMEGA THERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), VAXCYTE INC (NASDAQ), IMMUNOGEN INC (NASDAQ), MONTE ROSA THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), DICE THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), KURA ONCOLOGY INC (NASDAQ), NUVALENT INC (NASDAQ), MAXCYTE INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), FIBROGEN INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), JANUX THERAPEUTICS INC (NASDAQ), IMAGO BIOSCIENCES INC (NASDAQ), RANI THERAPEUTICS HLDGS INC (NASDAQ), BIOATLA INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), HUMACYTE INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), PERSONALIS INC (NASDAQ), VENTYX BIOSCIENCES INC (NASDAQ), IMMATICS N V (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AFFIMED N V (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), VBI VACCINES INC CDA (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), GRAPHITE BIO INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), NAUTILUS BIOTECHNOLOGY INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), MOLECULAR PARTNERS AG SPON ADS EACH REP 1 ORD SHS (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), VOR BIOPHARMA INC (NASDAQ), THESEUS PHARMACEUTICALS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), NKARTA INC (NASDAQ), AADI BIOSCIENCE INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ELIEM THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PASSAGE BIO INC (NASDAQ), GERON CORP (NASDAQ), 22ND CENTURY GROUP INC (NASDAQ), TIZIANA LIFE SCIENCES LTD (NASDAQ), VERASTEM INC (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), CHIMERIX INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), ALTIMMUNE INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), JASPER THERAPEUTICS INC (NASDAQ), HUMANIGEN INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), OMEROS CORP (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), VERA THERAPEUTICS INC. (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AEROVATE THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), INMUNE BIO INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), AKOUOS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), ONCORUS INC (NASDAQ), ATHERSYS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), COGNITION THERAPEUTICS INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), KAMADA LTD (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AVROBIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), IMMUNOME INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ATYR PHARMA INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ATRECA INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ELEVATION ONCOLOGY INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MIROMATRIX MEDICAL INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), CARDIOL THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), MEDICINOVA INC (NASDAQ), EQUILLIUM INC (NASDAQ), BIOVIE INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), GEMINI THERAPEUTIC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), CONTRAFECT CORP (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ),